1719.0000 24.40 (1.44%)
NSE Apr 07, 2026 12:42 PM
Volume: 1.0M
 

1719.00
1.44%
Phillip Capital
8 Given the +ve volume surprise in gGleevec and strong Taro performance, SUNP's Q4 earnings is 19% below our estimates. This implies weaker operating performance by SUNP'sbasebusinessandrelativelyweakerinventorypushingGleevec....
Sun Pharmaceutical Industries Ltd. is trading below its 30 day SMA of 1764.2
More from Sun Pharmaceutical Industries Ltd.
Recommended